Global Causes of Death to 2020Espicom Healthcare Intelligence
May 14, 2012
284 Pages - SKU: ESPI3938691
Additional InformationMortality statistics and forecasts by disease and country
With this report you can
Identify trends in 23 diseases/conditions and forecast patient population growth with data covering 2012-2020
Assess the current and future patient profile by cause of death by 55 leading and emerging markets
Evaluate at global and country level
Rank cause of death globally and identify areas of increasing need
Access original forecast data not in the public domain
Pdf and Espicom Interactive online formats included. Plus you can benefit from comprehensive user tools - Instant extraction of data to MS Excel™ or MS PowerPoint™!
This is the total health profile for 55 leading and emerging countries in 2010
How will this chart have changed by 2020?
Trends in mortality are key indicators to the health of a nation – and its current and future need for pharmaceutical and medical technology. Having practical and well organised access to that data is essential for sound marketing and business development planning.
The reasons behind the shifting outlook for cause of death rates are obviously numerous and complex. For the more developed countries in this study, the ageing population evidently plays a prominent role, with circulatory diseases and neoplasms accounting for the majority of deaths, but as healthcare technology and lifestyle improvements start to make an impact on related mortality, then other causes of death related to longevity become more prevalent, notably Mental & Behavioural Disorders and Nervous System Disorders (which include dementias).
For less developed countries, healthcare technology and health information may be less accessible, and therefore deaths from preventable or treatable diseases can be expected to continue to rise, for example circulatory disease, cancer and diabetes.
Growing populations do not indicate an ever increasing burden of need. By 2020, the death rate per 100,000 population is expected to fall globally in key conditions such as breast cancer and respiratory conditions.
Disease and conditions covered in the report
Infectious & Parasitic Diseases
Malignant Neoplasms, Digestive System
Malignant Neoplasms, Respiratory System
Malignant Neoplasms, Breast
Diseases of the Blood & Blood-Forming Organs
Endocrine, Nutritional & Metabolic Diseases
Mental & Behavioural Disorders
Diseases of the Nervous System & Sense Organs
Diseases of the Circulatory System
Ischaemic Heart Diseases
Diseases of the Respiratory System
Diseases of the Digestive System
Diseases of the Skin & Subcutaneous Tissue
Diseases of the Musculoskeletal System & Connective Tissue
Diseases of the Genito-urinary System
Pregnancy, Childbirth and Puerperium
Congenital Malformations & Chromosomal Anomalies
Injury, Poisoning & External Causes
Packed with statistics, Global Causes of Death is an easy-read pdf report which includes online access and easy to use user tools. It is an essential reference report for all executives working internationally in the global pharmaceutical, medtech and health provider industries.
Countries included in the report
United Arab Emirates
More Oncology/Hematology reports by Espicom Healthcare Intelligence
Targeted Cancer Drugs The Launch Landscape to 2018 by Espicom Healthcare Intelligence
As the cancer therapy market evolves, interest is growing in novel approaches which may supersede the current portfolio. In the short term, the market will ...
Emerging Drug Delivery Technologies & Strategies - Players, Pipelines & Partnerships by Espicom Healthcare Intelligence
An examination of trends and advances in the three major drug delivery sectors Unique sales forecasts to 2020 for key products Critical analyses ...
Breast Cancer Drug Discoveries: What the Future Holds by Espicom Healthcare Intelligence
In 2010, almost 50% of breast cancer sales were due to three branded targeted therapies. With a large unmet clinical need, further agents are required ...
Gastric Cancer Drug Discoveries: What the Future Holds by Espicom Healthcare IntelligenceSee all reports like this >>
Original analysis of the clinical potential and commercial prospects for companies, launched products and pipeline candidates put into current market context ...
More Global Oncology/Hematology reports
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives by Kalorama Information
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives Cancer testing is maturing from personalized medicine to precision medicine, where ...
Cancer Pain Global Clinical Trials Review, H1, 2013 by GlobalData
Cancer Pain Global Clinical Trials Review, H1, 2013SummaryGlobalData's clinical trial report, “Cancer Pain Global Clinical Trials Review, H1, 2013 provides data on the Cancer Pain ...
Global Leukemia Therapeutics Market 2012-2016 by Infiniti Research Limited
TechNavio's analysts forecast the Global Leukemia Therapeutics market to grow at a CAGR of 10 percent over the period 2012-2016. One of the key factors ...
Global Kidney Cancer Drugs Market 2012-2016 by Infiniti Research LimitedSee all reports like this >>
TechNavio's analysts forecast the Global Kidney Cancer Drugs market to grow at a CAGR of 13.4 percent over the period 2012-2016. One of the key ...
We can help you find what you need. Call us or write us:
Need help in your search?
- US Oncologist Survey: Optimizing Treatment for Advanced Melanoma
- Cancer Therapies Face Increasing Reimbursement Pressures in Europe and Japan
- Changes in U.S. Oncology Drug Reimbursement: Medicare Sets the Pace
- Cancer Therapeutics: Global Markets and Developments
- Angiogenesis Stimulators & Inhibitors: The Emerging World Market